Section Editor: Bibianna Purgina, MD FRCPC
October 3, 2026
A tenosynovial giant cell tumor is a noncancerous tumor that develops from the synovium. The synovium is the thin lining of joints, of the sheaths that surround tendons, and of the small fluid-filled sacs called bursae.
The form that develops along a tendon, most often in a finger, is still widely called a giant cell tumor of tendon sheath. Both names describe the same tumor, and you may see either on your report.
This tumor does not spread to other parts of the body. It can grow into nearby tissue and come back after surgery, and how often that happens depends on which of the two types you have.
This article explains how a tenosynovial giant cell tumor is diagnosed and what the findings in your pathology report mean.
Your report will usually state which type you have. The difference matters more than anything else in the report, because it determines the chance of the tumor coming back and the treatment options:
These tumors usually develop in adults in their 30s and 40s, although they can occur at any age. The localized type is about twice as common in women. The diffuse type affects men and women about equally.
Symptoms depend on the type:
Most of these tumors result from a change involving a gene called CSF1. The gene moves to a new position on a chromosome, causing it to make far too much of a protein that attracts immune cells.
Only a small proportion of tumor cells carry this change. Most of the tumor is made of immune cells drawn in by the extra protein, which is why the tumor contains such a mixture of cell types.
This change develops in the tumor during a person’s lifetime. It is not inherited and cannot be passed on to children. Doctors do not know what triggers it.
A pathologist makes the diagnosis after examining tumor tissue under a microscope. The tissue may come from a biopsy or from surgery that removes the tumor in an excision or resection. MRI is often done first, especially for the diffuse type, because it shows how far the tumor extends through the joint.
Under the microscope, the tumor is made of several kinds of cells mixed:
Additional tests are not usually needed. The combination of these cells, along with the tumor’s location, is enough for the diagnosis.
No. Despite the similar name, a giant cell tumor of bone is a different tumor. It starts inside a bone, has a different genetic cause, and is treated differently. Both contain large cells with many nuclei, which is where the shared name comes from.
A margin is the edge of tissue cut by the surgeon. Your report may note whether the tumor reaches the cut edge.
For a localized tumor, a positive margin raises the chance that the tumor comes back in the same spot. For the diffuse type, complete removal is often not possible, because the tumor spreads through the joint lining. A positive margin is common in that situation and is one reason the diffuse type recurs more often.
The outlook is very good. A tenosynovial giant cell tumor is noncancerous, does not spread, and does not become cancer.
The main issue is that it can come back. After surgery, the localized type comes back in fewer than 15% of people. The diffuse type comes back much more often, in up to roughly half of people in some studies. Repeated recurrence can damage the joint over time, which is why newer medications have become an important option for the diffuse type.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name